SCHEMBL18044454

SCHEMBL18044454

CCCOCCOCCOc1ccc(F)c(F)c1C(=O)c1ccc(C(=O)OC)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.43
▸ TDP1 Q9NUW8 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ TTR P02766 1/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ ABCB11 O95342 1/20 0.38
▸ ADRA2B P18089 1/20 0.38
▸ OPRD1 P41143 1/20 0.38
▸ SCN5A Q14524 1/20 0.38
▸ NLRP3 Q96P20 1/20 0.38
▸ ERN1 O75460 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18151911 0.92 MAPT (0.44) MAPTTDP1L3MBTL1SMN1; SMN2KDM4E
SCHEMBL18499051 0.92 MAPT (0.44) MAPTTDP1L3MBTL1SMN1; SMN2KDM4E
SCHEMBL18044471 0.92 MAPT (0.44) MAPTTDP1L3MBTL1SMN1; SMN2KDM4E
SCHEMBL18044474 0.91 MAPT (0.43) MAPTTDP1L3MBTL1SMN1; SMN2KDM4E
SCHEMBL18044486 0.91 MAPT (0.43) MAPTTDP1L3MBTL1SMN1; SMN2KDM4E
SCHEMBL20709124 0.88 PDE4D (0.39) MAPTL3MBTL1KDM4EALDH1A1LMNA
SCHEMBL18151908 0.88 RARB (0.46) ALDH1A1LMNAHPGDRAB9AKMT2A
SCHEMBL20709025 0.85 MAPT (0.44) MAPTTDP1L3MBTL1ALDH1A1LMNA
SCHEMBL20709061 0.83 RXRA (0.35) MAPTL3MBTL1KDM4ELMNAPDE4D
SCHEMBL18010709 0.83 PDE4D (0.48) MAPTTDP1L3MBTL1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3067351-B1 COMPOUND HAVING HIGHER INHIBITION OF PROTEIN KINASE G ACTIVITY AND PREPARATION METHOD THEREFOR JENKEM TECH CO LTD TIANJIN (CN) 2019-02-06 — — EP disclosed
EP-3067351-B1 COMPOUND HAVING HIGHER INHIBITION OF PROTEIN KINASE G ACTIVITY AND PREPARATION METHOD THEREFOR JENKEM TECH CO LTD TIANJIN (CN) 2019-02-06 — — EP disclosed
US-9925171-B2 Compound having higher inhibitory activity on protein kinase G and preparation method thereof Jenkem Technology Co., Ltd., (Tianjin) (CN) 2018-03-27 — — US disclosed
US-9925171-B2 Compound having higher inhibitory activity on protein kinase G and preparation method thereof Jenkem Technology Co., Ltd., (Tianjin) (CN) 2018-03-27 — — US disclosed
US-9925171-B2 Compound having higher inhibitory activity on protein kinase G and preparation method thereof Jenkem Technology Co., Ltd., (Tianjin) (CN) 2018-03-27 — — US disclosed
US-20170119736-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF Jenkem Technology Co., Ltd., (Tianjin) (CN) 2017-05-04 — — US disclosed
US-20170119736-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF Jenkem Technology Co., Ltd., (Tianjin) (CN) 2017-05-04 — — US disclosed
US-20170119736-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF Jenkem Technology Co., Ltd., (Tianjin) (CN) 2017-05-04 — — US disclosed
US-9567319-B2 Compound having higher inhibitory activity on protein kinase G and preparation method thereof JENKEM TECHNOLOGY CO. LTD., (TIANJIN) (CN) 2017-02-14 — — US disclosed
US-9567319-B2 Compound having higher inhibitory activity on protein kinase G and preparation method thereof JENKEM TECHNOLOGY CO. LTD., (TIANJIN) (CN) 2017-02-14 — — US disclosed
US-9567319-B2 Compound having higher inhibitory activity on protein kinase G and preparation method thereof JENKEM TECHNOLOGY CO. LTD., (TIANJIN) (CN) 2017-02-14 — — US disclosed
US-20160304501-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF Jenkem Technology Co., Ltd., (Tianjin) (CN) 2016-10-20 — — US disclosed
US-20160304501-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF Jenkem Technology Co., Ltd., (Tianjin) (CN) 2016-10-20 — — US disclosed
US-20160304501-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF Jenkem Technology Co., Ltd., (Tianjin) (CN) 2016-10-20 — — US disclosed
EP-3067351-A1 COMPOUND HAVING HIGHER INHIBITION OF PROTEIN KINASE G ACTIVITY AND PREPARATION METHOD THEREFOR Jenkem Technology Co. Ltd. (Tianjin) (CN) 2016-09-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304501-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF PRKCG, PRKG2, PKN3 MAPT 4286/4885TDP1 4022/4885L3MBTL1 3411/4885
US-20170119736-A1 COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF PRKCG, PRKG2, PKN3 MAPT 4286/4885TDP1 4022/4885L3MBTL1 3411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback